已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Denosumab Induces Tumor Reduction and Bone Formation in Patients with Giant-Cell Tumor of Bone

德诺苏马布 骨巨细胞瘤 兰克尔 间质细胞 医学 巨细胞 病理 巨细胞瘤 癌症研究 内科学 骨质疏松症 受体 激活剂(遗传学)
作者
Dan Branstetter,Scott D. Nelson,J. Carlos Manivel,Jean‐Yves Blay,Sant P. Chawla,David M. Thomas,Susie Jun,Ira Jacobs
出处
期刊:Clinical Cancer Research [American Association for Cancer Research]
卷期号:18 (16): 4415-4424 被引量:359
标识
DOI:10.1158/1078-0432.ccr-12-0578
摘要

Abstract Purpose: Giant-cell tumor of bone (GCTB) is a locally aggressive, benign osteolytic tumor in which bone destruction is mediated by RANK ligand (RANKL). The RANKL inhibitor denosumab is being investigated for treatment of GCTB. We describe histologic analyses of GCTB tumor samples from a phase II study of denosumab in GCTB. Experimental Design: Adult patients with recurrent or unresectable GCTB received subcutaneous denosumab 120 mg every 4 weeks (with additional doses on days 8 and 15). The primary histologic efficacy endpoint was the proportion of patients who had a 90% or more elimination of giant cells from their tumor. Baseline and on-study specimens were also evaluated for overall tumor morphology and expression of RANK and RANKL. Results: Baseline tumor samples were typically composed of densely cellular proliferative RANKL-positive tumor stromal cells, RANK-positive rounded mononuclear cells, abundant RANK-positive tumor giant cells, and areas of scant de novo osteoid matrix and woven bone. In on-study samples from 20 of 20 patients (100%), a decrease of 90% or more in tumor giant cells and a reduction in tumor stromal cells were observed. In these analyses, thirteen patients (65%) had an increased proportion of dense fibro-osseous tissue and/or new woven bone, replacing areas of proliferative RANKL-positive stromal cells. Conclusions: Denosumab treatment of patients with GCTB significantly reduced or eliminated RANK-positive tumor giant cells. Denosumab also reduced the relative content of proliferative, densely cellular tumor stromal cells, replacing them with nonproliferative, differentiated, densely woven new bone. Denosumab continues to be studied as a potential treatment for GCTB. Clin Cancer Res; 18(16); 4415–24. ©2012 AACR.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
赘婿应助大调查师朱诺采纳,获得10
2秒前
sss完成签到,获得积分10
3秒前
echopussy应助眼睛大香芦采纳,获得10
4秒前
4秒前
情怀应助听话的梦之采纳,获得10
5秒前
7秒前
8秒前
Sky发布了新的文献求助10
9秒前
10秒前
淡然幻梦发布了新的文献求助10
11秒前
12秒前
sss发布了新的文献求助10
14秒前
追寻定帮发布了新的文献求助10
15秒前
15秒前
Hello应助LIM采纳,获得10
16秒前
大模型应助青城粘豆包采纳,获得10
16秒前
18秒前
18秒前
19秒前
20秒前
伊斯塔发布了新的文献求助10
22秒前
22秒前
22秒前
春辞发布了新的文献求助30
23秒前
23秒前
sciN完成签到 ,获得积分10
24秒前
亮liang发布了新的文献求助10
24秒前
25秒前
田様应助追寻定帮采纳,获得10
25秒前
江上清风发布了新的文献求助20
25秒前
小二郎应助蓝桉采纳,获得10
25秒前
25秒前
26秒前
无奈绮琴完成签到,获得积分10
26秒前
27秒前
黄佳妮发布了新的文献求助10
27秒前
28秒前
huangxuanyu发布了新的文献求助10
29秒前
ufofly730完成签到 ,获得积分10
29秒前
伊斯塔完成签到,获得积分10
30秒前
高分求助中
All the Birds of the World 3000
Weirder than Sci-fi: Speculative Practice in Art and Finance 960
IZELTABART TAPATANSINE 500
Introduction to Comparative Public Administration: Administrative Systems and Reforms in Europe: Second Edition 2nd Edition 300
Spontaneous closure of a dural arteriovenous malformation 300
GNSS Applications in Earth and Space Observations 300
Not Equal : Towards an International Law of Finance 260
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 物理 生物化学 纳米技术 计算机科学 化学工程 内科学 复合材料 物理化学 电极 遗传学 量子力学 基因 冶金 催化作用
热门帖子
关注 科研通微信公众号,转发送积分 3725119
求助须知:如何正确求助?哪些是违规求助? 3270218
关于积分的说明 9965062
捐赠科研通 2985172
什么是DOI,文献DOI怎么找? 1637795
邀请新用户注册赠送积分活动 777724
科研通“疑难数据库(出版商)”最低求助积分说明 747164